Gene search

Sequence information

Select Gene Cds Cds_length GC_content Pep Pep_length
Vivi1g08844 ATGGTTTCTTTTACCTTAATTTTCTTCACTCTGTTTTCTGTTCTGTTTTCCTCTGTTTCTTCATCTACTTTGCGTAGCGATTTTCATGCTTTGGTCAGTCTTAAACAAGGTTTTCAATTCTCAAACCAAGTTCTAAACACATGGGAAGATTCAAATTTCACTTCAATTTGTTCATGGACTGGAATTCAATGCCGGGAGAATCGAATAGTCTCTCTCGACTTAACCGATTTGAATCTGTTTGGCTCTGTTTCACCTTCAATCACATCACTTGACAAACTCACACACCTTTCTCTAGCAGGAAACAACTTCACAGGAACCATTCACCTCACAAACTTAACCAACCTTGAGTTTCTAAACATCTCCAACAACATGTTCAATGGTCACATGGATCATTGGAGCTTCTCCACCATGCAAAACCTTCAAGTCCTTGATGTGTACAACAACAATTTCACTTCATTGCTTCCATTAGGCCTTCTTCCCTTGAACCAAACCCTCAAACACTTGGATCTTGGTGGTAACTTTTTCTTCGGCGAAATCCCGAAAAGCTTTGGAGAATTTAGTTCTCTTGAGTATCTTTCACTGGCTGGAAATGACATCACAGGAAAAATCCCTGGTGAGTTAGGAAATCTGAGTAACTTGAAGGAAATTTACTTGGGCTATTACAATTCCTTTGAAGGTGGAATTCCAACCGAATTCGGAAAGTTAACAAATCTTGTTCATATGGATCTTTCAAGCTGTGATTTGAATGGTTCCATCCCAAAAGAGTTAGGTGAATTGAGAAAACTCAACACACTTTACTTGCATATAAACCAGCTTTCGGGTTCGTTACCAAAACATCTTGGTAACTTAACAGAACTTCTCTACCTCGATCTTTCGAGCAATGTACTCACCGGAGAAATTCCGTTCGAGTTCATGAATCTCAAGAATCTCAAGCTGATCAACCTTTTTTTAAACAGGTTTCATGGTTCAATACCGGAGTACATTGCGGATTTTCCTGATTTAGAAACTCTTGGTTTGTGGATGAACAATTTCACTGGCGAAATTCCATATAAACTCGGCCTCAATGGGAAGATTCGAGTCCTTGATTTGTCGTCTAATAAACTCACTGGTGTTATTCCGCCGAATCTTTGTTCTTCAAACCAGCTTAACATTTTGATTCTTCTTAACAATTTTCTGTTTGGTCCTATACCAGAAGGTCTAGGAACATGTTATAGTCTCACTAGAGTGAGATTAGGAGAGAATTACCTTAATGGTAGTATTCCAGATGGTTTTCTTTATCTTCCTAAGCTAAATTTAGCTGAGTTGAAGAACAATTACTTGTCTGGAACATTGTTAGAAAATGGTAACGGTTCGTCTTTTTCTCAGTCGAAGCCTGTTTGTTTAGAACAGCTTGATTTGTCGAACAATGCGTTGTCTGGTCCTTTACCGCATTCCCTCTCGAATTTCACTTCGCTTCAGATACTTTTCCTTGGTGGAAACCAGTTTTCGGGTCCGATTCCAAGTTCCATTGGAGGACTTAACCAAGTGTTGAAGCTTGACCTTAGCAGAAACTTGTTATCGGGTGAAATTCCGCCCGATATCGGAAACTGTGTTCATCTTACCTATCTTGACATGAGCCAGAATAATCTTTCTGGCTCGATTCCACCGTTGTTTTCGAATATTCGTATTTTGAATTACTTGAACCTGTCTAGAAACCATTTGAACCAAAGCATACCAAAGTCAATAGGGACAATGAAAAGCCTCACTGTTGCTGATTTCTCCTTCAACGAATTCTCTGGTAAATTGCCCGAATCAGGCCAGTTTTCGTTCTTTAACGCGTCTGCGTTCGCAGGGAATCCTAAACTATGTGGCTCTCTATTGAACAATCCATGTAAATTGACAGGAATGAAGTCCACACCAGGAAAAAAAAGCAATGCAGATTTCAAGCTGATATTCGCGCTCGGGCTATTGGTATGTTCGTTAGTCTTTGTTATCGCAGCGATTCTAAAAGCCAAGTCATTCAAAAAGAATGGCCCTGGTTCTTGGAAGATGACTGCATTCAAAAAGCTCGAGTTCACCGTTTCAGACATCCTCGAATGCGTGAAAGACGGTAACGTGATAGGAAGAGGAGGCGCAGGGATAGTTTACCACGGAAAAATGCCGAATGGAGTAGAAATAGCAGTAAAAAAACTACTCGGGTTCGGCGCAAATAGTCACGATCATGGTTTTAGAGCTGAAATTCAAACACTTGGAAACATAAGACACAGAAACATTGTGAGACTACTTGCATTCTGTTCAAACAAAGAAACAAATCTTCTTGTGTATGAATACATGAGAAATGGGAGCTTAGGTGAAGCATTGCATGGAAAAAAAGGCGCATTCTTGAGTTGGAACTTTCGGTACAAGATATCTATTGATTCTGCTAAAGGACTATGCTATCTTCACCATGATTGTTCTCCATTGATCCTACACCGAGATGTGAAATCTAACAACATTTTGTTGAGTTCGAATTTCGAAGCGCATGTTGCCGATTTCGGACTAGCGAAATTCTTGGTTGATGGCGCTGCGTCTGAATGCATGTCTTCAATTGCAGGATCATATGGTTACATTGCACCAGAATATGCATACACATTAAGAGTGGATGAAAAAAGTGATGTTTATAGTTTTGGAGTAGTTCTACTAGAGTTACTAACTGGTAAAAAACCAGTTGGTGATTTTGGAGAAGGAGTAGATCTTGTACAATGGTGCAAAAAAGCAACAAATGGAAGAAGAGAACAAGTCATCAACATAATCGATTCAAGACTCATGGTAGTGCCAAGAGAAGAAGCCATGCACATGTTCTTCATTGCAATGCTATGCTTAGAAGAAAACAGTGTTCAAAGACCAACCATGAGAGAAGTTGTTCAGATGCTTTCTGAATTTCCAAGACAATCACAACAACAAGAACATCAACAATCTTCTTCTTCATGTTCTTCTAGTGTTAATCCACCAAGCAAAAAGTTAATTCAGAATCATAAATTGCCTTGTTCTCCTACTTTTAAACATGATCTTTTGGTTTAA 3039 0.3922 MVSFTLIFFTLFSVLFSSVSSSTLRSDFHALVSLKQGFQFSNQVLNTWEDSNFTSICSWTGIQCRENRIVSLDLTDLNLFGSVSPSITSLDKLTHLSLAGNNFTGTIHLTNLTNLEFLNISNNMFNGHMDHWSFSTMQNLQVLDVYNNNFTSLLPLGLLPLNQTLKHLDLGGNFFFGEIPKSFGEFSSLEYLSLAGNDITGKIPGELGNLSNLKEIYLGYYNSFEGGIPTEFGKLTNLVHMDLSSCDLNGSIPKELGELRKLNTLYLHINQLSGSLPKHLGNLTELLYLDLSSNVLTGEIPFEFMNLKNLKLINLFLNRFHGSIPEYIADFPDLETLGLWMNNFTGEIPYKLGLNGKIRVLDLSSNKLTGVIPPNLCSSNQLNILILLNNFLFGPIPEGLGTCYSLTRVRLGENYLNGSIPDGFLYLPKLNLAELKNNYLSGTLLENGNGSSFSQSKPVCLEQLDLSNNALSGPLPHSLSNFTSLQILFLGGNQFSGPIPSSIGGLNQVLKLDLSRNLLSGEIPPDIGNCVHLTYLDMSQNNLSGSIPPLFSNIRILNYLNLSRNHLNQSIPKSIGTMKSLTVADFSFNEFSGKLPESGQFSFFNASAFAGNPKLCGSLLNNPCKLTGMKSTPGKKSNADFKLIFALGLLVCSLVFVIAAILKAKSFKKNGPGSWKMTAFKKLEFTVSDILECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGANSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLSWNFRYKISIDSAKGLCYLHHDCSPLILHRDVKSNNILLSSNFEAHVADFGLAKFLVDGAASECMSSIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGKKPVGDFGEGVDLVQWCKKATNGRREQVINIIDSRLMVVPREEAMHMFFIAMLCLEENSVQRPTMREVVQMLSEFPRQSQQQEHQQSSSSCSSSVNPPSKKLIQNHKLPCSPTFKHDLLV 1012
       

Annotation information

Select Seq ID Length Analysis Description Start End IPR GO
Vivi1g08844 1012 SUPERFAMILY RNI-like 71 571 - -
Vivi1g08844 1012 Gene3D Ribonuclease Inhibitor 26 130 IPR032675 -
Vivi1g08844 1012 Gene3D Ribonuclease Inhibitor 221 281 IPR032675 -
Vivi1g08844 1012 FunFam Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM3 223 328 - -
Vivi1g08844 1012 ProSiteProfiles Protein kinase domain profile. 694 968 IPR000719 GO:0004672|GO:0005524|GO:0006468
Vivi1g08844 1012 Gene3D Ribonuclease Inhibitor 359 630 IPR032675 -
Vivi1g08844 1012 MobiDBLite consensus disorder prediction 967 1000 - -
Vivi1g08844 1012 SUPERFAMILY Protein kinase-like (PK-like) 685 964 IPR011009 -
Vivi1g08844 1012 FunFam Leucine-rich repeat receptor-like serine/threonine-protein kinase 771 981 - -
Vivi1g08844 1012 Gene3D Transferase(Phosphotransferase) domain 1 771 989 - -
Vivi1g08844 1012 ProSitePatterns Serine/Threonine protein kinases active-site signature. 815 827 IPR008271 GO:0004672|GO:0006468
Vivi1g08844 1012 PANTHER LRR RECEPTOR-LIKE SERINE/THREONINE-PROTEIN KINASE-RELATED 231 965 - -
Vivi1g08844 1012 FunFam Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM3 335 628 - -
Vivi1g08844 1012 SMART LRR_typ_2 137 160 IPR003591 -
Vivi1g08844 1012 SMART LRR_typ_2 186 210 IPR003591 -
Vivi1g08844 1012 SMART LRR_typ_2 259 283 IPR003591 -
Vivi1g08844 1012 SMART LRR_typ_2 356 379 IPR003591 -
Vivi1g08844 1012 SMART LRR_typ_2 506 530 IPR003591 -
Vivi1g08844 1012 SMART LRR_typ_2 554 578 IPR003591 -
Vivi1g08844 1012 SMART LRR_typ_2 112 136 IPR003591 -
Vivi1g08844 1012 Pfam Leucine Rich Repeat 357 377 IPR001611 GO:0005515
Vivi1g08844 1012 Pfam Leucine Rich Repeat 532 553 IPR001611 GO:0005515
Vivi1g08844 1012 SUPERFAMILY L domain-like 297 443 - -
Vivi1g08844 1012 SMART serkin_6 694 968 IPR000719 GO:0004672|GO:0005524|GO:0006468
Vivi1g08844 1012 Pfam Leucine rich repeat 164 220 IPR001611 GO:0005515
Vivi1g08844 1012 Pfam Protein tyrosine and serine/threonine kinase 697 964 IPR001245 GO:0004672|GO:0006468
Vivi1g08844 1012 Gene3D Ribonuclease Inhibitor 131 220 IPR032675 -
Vivi1g08844 1012 Gene3D Ribonuclease Inhibitor 282 358 IPR032675 -
Vivi1g08844 1012 FunFam Leucine-rich repeat receptor-like kinase 26 133 - -
Vivi1g08844 1012 FunFam Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM3 134 222 - -
Vivi1g08844 1012 Gene3D Phosphorylase Kinase; domain 1 659 770 - -
Vivi1g08844 1012 FunFam Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM1 663 770 - -
Vivi1g08844 1012 Pfam Leucine rich repeat N-terminal domain 26 64 IPR013210 -
Vivi1g08844 1012 ProSiteProfiles Leucine-rich repeat profile. 139 160 IPR001611 GO:0005515
Vivi1g08844 1012 MobiDBLite consensus disorder prediction 967 993 - -
       

Duplication type information

Select Gene Chromosome Start End Duplicated_type
Vivi1g08844 Vivi-Chr1 252268630 252273463 Transposed
       

Functional genes information

Select Gene Gene_start Gene_end Function Ath_gene Identity(%) E-value Score
Vivi1g08844 26 991 Receptor kinase-like Gene Family AT5G65700 56.837 0.0 1090
       

Transcription factors information

Select Regulatory Factors Family Gene Hmm_acc Hmm_name E_value Clan
PK RLK-Pelle_LRR-XI-1 Vivi1g08844 PK_Tyr_Ser-Thr 2.3e-44 CL0016
       

Pathway information

Select Query KO Definition Second KO KEGG Genes ID GHOSTX Score
Vivi1g08844 - - qsa:O6P43_031479 1490.32